Search results
Results from the WOW.Com Content Network
A recall has been ordered for a high-profile diabetes drug after producers discovered it contained alarmingly high levels of a cancer-causing impurity. Marksans Pharma Limited has recalled ...
Keele Valley Landfill#Resident class action lawsuit; Kemper Corporation#Class-action lawsuit; Kids for cash scandal#Victim lawsuits; Kweku Hanson#Class action lawsuit against Ocwen Federal FSB; Lead contamination in Washington, D.C. drinking water#Class-action lawsuit; Long-term effects of benzodiazepines#Class-action lawsuit; Lowe's#Lawsuits
Lists of lawsuits cover various types of lawsuits. They are organized by topics and fields, and by individual companies or people. They are organized by topics and fields, and by individual companies or people.
The FTC sued UnitedHealth Group's Optum unit, CVS Caremark and Cigna's Express Scripts for allegedly steering diabetes patients towards higher priced insulin.
Liraglutide, sold under the brand name Victoza among others, is an anti-diabetic medication used to treat type 2 diabetes, and chronic obesity. [6] [7] It is a second-line therapy for diabetes following first-line therapy with metformin. [6] [8] Its effects on long-term health outcomes like heart disease and life expectancy are unclear.
In the United States, sitagliptin/metformin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. [5] [6]In the European Union, sitagliptin/metformin is indicated as an adjunct to diet and exercise to improve glycemic control in people with type 2 diabetes; in combination with a sulfonylurea as an adjunct to diet and exercise "in people ...
Of the diabetes drugs prescribed off-label for weight loss, metformin is one of the most well-researched. If you have obesity or are struggling to lose weight, talk to a healthcare provider about ...
Empagliflozin/metformin was approved for use in the European Union in May 2015. [6] Empagliflozin/metformin was approved for use in the United States in August 2015. [7] [12] The extended release version was approved for use in the United States in December 2016. [13] [14] Empagliflozin/metformin was approved for use in Australia in May 2020. [2]